ROIV

ROIV

USD

Roivant Sciences Ltd. Common Shares

$19.870+0.320 (1.637%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigtes Königreich

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$19.550

Hoch

$19.890

Tief

$19.315

Volumen

9.01M

Unternehmensfundamentaldaten

Marktkapitalisierung

13.6B

Branche

Biotechnologie

Land

United Kingdom

Handelsstatistiken

Durchschnittliches Volumen

7.66M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $8.73Aktuell $19.870Hoch $20.085

Ähnliche Nachrichten

GlobeNewswire

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update

BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today reported its financial results for the second quarter ended September 30, 2025, and provided a business update.

Mehr anzeigen
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
Analyst Upgrades

Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25

Citigroup analyst Samantha Semenkow maintains Roivant Sciences with a Buy and raises the price target from $16 to $25.

Mehr anzeigen
Citigroup Maintains Buy on Roivant Sciences, Raises Price Target to $25
GlobeNewswire

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.

Mehr anzeigen
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
GlobeNewswire

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

BASEL, Switzerland and LONDON and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Roivant (NASDAQ:ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 10, 2025, to

Mehr anzeigen
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025